Patent · US Active

Method of producing biologically active polypeptide having insulinotropic activity

US8114632B2 · kind B2 · utility

15Cited by
2References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2007
Grant dateFeb 14, 2012
Priority date
Expiry dateMay 29, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/46
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a method of producing a biologically active polypeptide having insulinotropic activity, the method comprising steps of: (a) transforming a genetically modified host cell that has protease gene knockout, with a polynucleotide vector encoding the polypeptide; and (b) growing the transformed host cell to produce the biologically active polypeptide; and a method of producing a biologically active polypeptide having an N-terminal recognition site His-Gly with insulinotropic activity, the method comprising steps of: (a) transforming a genetically modified Pichia pastoris that has protease gene STE13 knockout, with a polynucleotide vector encoding the polypeptide; and (b) growing the transformed Pichia pastoris to produce the biologically active polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.